BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1737364)

  • 21. Lack of BCL-2 confers interferon-alpha sensitivity to B-cell lymphomas.
    Karauzum SB; Yasar D; Dirice E; Imir N; Luleci G; Ozes ON
    Growth Factors; 2007 Apr; 25(2):94-100. PubMed ID: 17852408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
    Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
    Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features.
    Paoletti M; Bitter MA; Vardiman JW
    Clin Lab Med; 1988 Mar; 8(1):179-95. PubMed ID: 3282758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
    Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
    Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT; Mold NG
    Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
    Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
    Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alpha interferon treatment in hairy cell leukemia].
    Hagberg H
    Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
    Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
    Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating hairy cell leukemia dysregulations. Looking for interferon alpha site of action in hairy cells.
    Genot E; Wietzerbin J
    Leuk Lymphoma; 1994; 14 Suppl 1():23-6. PubMed ID: 7820049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
    Wagner L; Goldstone AH; Worman CP
    Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon alpha and intracytoplasmic free calcium in hairy cell leukemia cells.
    Genot E
    Leuk Lymphoma; 1994 Feb; 12(5-6):373-81. PubMed ID: 8180601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of biological activity of interferons.
    Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
    Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired interferon alpha response in hairy cell leukemia is corrected by therapy with 2-chloro-2'-deoxyadenosine: implications for susceptibility to opportunistic infections.
    Siegal FP; Shodell M; Shah K; Drake D; Hoffman M; Sawitsky A; Janson D; Fitzgerald-Bocarsly P; Rai KR
    Leukemia; 1994 Sep; 8(9):1474-9. PubMed ID: 7916389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
    Genot E; Billard C; Sigaux F; Mathiot C; Degos L; Falcoff E; Kolb JP
    Leukemia; 1987 Aug; 1(8):590-6. PubMed ID: 2444836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
    Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.